Neurotechnology is becoming a governance problem
For years, brain–computer interfaces sat at the edge of medicine and engineering: impressive in demonstrations, important for a small number of patients, but distant from everyday politics. That is changing. Advances in sensing, signal processing and machine learning have made it easier to decode patterns of neural activity for communication, movement and diagnosis. At the same time, consumer-facing neurotechnology, from wearable sensors to attention-tracking systems, has broadened the field beyond specialist clinics.
The result is that questions once treated as philosophical are becoming practical. What protections should apply to data generated by the brain? Can mental states be inferred, profiled or manipulated in ways that outpace existing privacy law? And should there be distinct protections for cognition itself, rather than merely for devices or medical records?
These questions sit at the heart of the emerging debate on cognitive liberty and neurorights. They are not arguments against neurotechnology. Properly governed, neural interfaces could improve communication for paralysed patients, support rehabilitation after injury and deepen understanding of neurological disease. But because these systems touch the organ most closely associated with identity, intention and agency, their social implications are unusually intimate.
Neurotechnology does not merely collect information about the body; in some cases it reaches towards the processes by which people form intention, emotion and choice.
That is why the governance discussion increasingly turns on more than safety and efficacy. It extends to mental privacy, freedom from coercive monitoring, limits on behavioural influence and the ownership, access and use of neurodata.
What neural interfaces actually do
Neural interfaces come in several forms. Some are invasive, involving electrodes implanted in or on the brain to record activity with high fidelity or stimulate neural tissue directly. Others are non-invasive, using electroencephalography, functional near-infrared spectroscopy or related methods to detect broader patterns from outside the skull. The technical differences matter because they shape both capability and risk.
In clinical settings, invasive systems have enabled some people with severe paralysis to control cursors, spell text and operate assistive devices. Research published in leading journals has shown notable progress in restoring communication and movement-related control. Deep brain stimulation, though not usually discussed under the consumer label of brain–computer interfaces, is already an established neuromodulation therapy for conditions such as Parkinson’s disease, and demonstrates how stimulation can alter brain function for therapeutic benefit.
Non-invasive systems are generally less precise, but easier to deploy and therefore more likely to spread widely. They are used in research, wellness applications, education experiments and workplace pilots. Their present limits should not invite complacency. A tool need not read thoughts in cinematic detail to raise civil-liberties concerns. If it can infer fatigue, attention, recognition, emotional arousal or susceptibility with commercially useful accuracy, it can already affect power relations between individuals, employers, platforms and the state.
Much of the public conversation still swings between two errors: assuming that neurotechnology is either science fiction or omnipotent. It is neither. The prudent stance is to recognise that useful, narrow inference from neural signals is real today, while richer forms of decoding and intervention are likely to improve over time.
Why neurodata is different
All personal data deserves protection, but neurodata presents several features that make it unusually sensitive. First, it may reveal information that a person has not consciously chosen to disclose. A typed message, spoken statement or social-media post is an act of expression. Neural signals may be recorded passively, continuously or indirectly, producing insights that the subject neither intended nor even fully understood.
Neurotechnology does not merely collect information about the body; in some cases it reaches towards the processes by which people form intention, emotion and choice.
Secondly, neural data can be probabilistic yet still consequential. It may not show a single unambiguous thought; rather, it may support inferences about mood, recognition, cognitive load, impulsivity or impairment. In many real-world settings, such inferences are enough to shape decisions about insurance, employment, education, policing or access to services.
Thirdly, neural data may be difficult to treat as fully separable from the person. A password can be changed. A credit-card number can be replaced. Patterns in brain activity linked to health, preference or vulnerability are not so easily rotated away after a breach. This does not mean neurodata is mystical or beyond regulation. It means conventional data-governance models, built around notice, consent and after-the-fact redress, may be inadequate on their own.
The core issue is not whether devices can literally read minds, but whether institutions can draw actionable inferences from neural signals before law and norms catch up.
UNESCO’s recent work on the ethics of neurotechnology has stressed exactly this point: that neurotechnology combines the capacities of medicine, computation and surveillance in ways that pressure existing categories of governance. The challenge is therefore to decide when neural data should be treated as health data, biometric data, a special class of sensitive information, or something requiring its own legal approach.
The case for cognitive liberty
Cognitive liberty is the idea that people should have meaningful freedom over their own mental processes. In its strongest formulation, it includes both a positive freedom to use lawful tools to alter or augment one’s cognition, and a negative freedom from unwanted intrusion, coercion or manipulation. The concept has gained traction because older civil-liberties frameworks do not neatly address technologies aimed at monitoring or influencing the brain directly.
The attraction of cognitive liberty is that it focuses on agency. Debates about privacy often centre on secrecy: who knows what, and under what conditions. Debates about bodily autonomy centre on physical intervention. Neurotechnology can implicate both, but it also raises a further issue: whether a person retains practical control over the formation and expression of thought.
This is particularly salient where institutions have unequal bargaining power. A worker might be asked to wear a cognitive-monitoring headset in the name of safety or productivity. A student might be nudged towards attention-tracking systems as part of learning analytics. A defendant, migrant or soldier might face stronger forms of pressure. In such settings, formal consent may be legally present while substantively weak.
Cognitive liberty therefore acts as a bridge concept. It links data protection, bodily integrity, freedom of thought and anti-discrimination to a domain where all of them may be implicated at once. Critics sometimes worry that the term is too broad to legislate. But as a policy lens it is useful, because it asks a prior question: what kinds of mental access or influence should be off-limits regardless of commercial efficiency or administrative convenience?
Neurorights are entering law and policy
The most prominent attempt to answer that question has come through the language of neurorights. Scholars and advocacy groups have proposed a cluster of protections, typically including mental privacy, personal identity, free will or agency, fair access to augmentation, and protection against algorithmic bias in neurotechnology. The idea is not that all existing rights are obsolete. Rather, it is that neurotechnology may stretch them to breaking point unless interpreted or updated explicitly.
Chile has been the best-known early mover. It amended its constitution in 2021 to recognise the need to protect brain activity and information derived from it, and has debated accompanying legislation. The move was symbolically important because it treated the issue as foundational rather than merely technical. International bodies have also begun to engage. UNESCO adopted a Recommendation on the Ethics of Neurotechnology in 2025, framing neurotechnology as a matter of human dignity, rights and responsible innovation. The OECD has published recommendations on responsible innovation in neurotechnology, emphasising stewardship, safety, inclusiveness and trustworthiness.
Even so, there remains a gap between principle and enforcement. Terms such as identity and free will are powerful but difficult to operationalise. Regulators tend to work best with clearer obligations: data minimisation, purpose limitation, auditability, security, prohibitions on compelled access and strict rules on secondary use. The practical future of neurorights may therefore lie less in creating wholly new legal silos than in combining constitutional principles with concrete sectoral rules.
Rights language matters, but rights become real only when they are translated into duties on data collection, inference, access, retention and use.
The core issue is not whether devices can literally read minds, but whether institutions can draw actionable inferences from neural signals before law and norms catch up.
Mental privacy is more than data protection
Mental privacy is often treated as a subset of informational privacy. In one sense it is: neural signals are data, and data rules apply. But mental privacy reaches further. It concerns the protected space in which beliefs, memories, reactions and intentions can exist without unauthorised extraction or pressure. That makes it closely related to freedom of thought, a right recognised in international human-rights law but historically underdeveloped because thought itself was hard to access.
Now that assumption is weakening. No current technology offers transparent access to the total contents of a person’s mind. Yet partial access may be enough to erode the spirit of the protection. If systems can identify recognition, emotional salience or concentration under constrained conditions, the zone of mental opacity narrows. That matters especially in settings marked by hierarchy: prisons, borders, schools, workplaces, hospitals and militaries.
A robust approach to mental privacy would therefore include at least four elements. First, a presumption against collecting neural data except where necessary and proportionate. Secondly, heightened consent standards, including clear bans on coercive or bundled consent. Thirdly, restrictions on inferential use, not just raw-data access. And fourthly, a strong prohibition on compelled disclosure or extraction of neural information except under extremely narrow, scrutinised conditions, if at all.
This is also where existing legal frameworks may diverge. Health law, consumer protection, labour law, anti-discrimination law and human-rights law each cover part of the terrain. Neurotechnology exposes the seams between them.
The market for neurodata could outgrow medical ethics
Historically, much neurotechnology developed in clinical or academic settings where medical ethics, professional duties and research oversight offered some protection. As the field broadens, those guardrails become patchier. Consumer devices may not be regulated as medical instruments. Data may flow through app ecosystems, cloud infrastructure and analytics pipelines designed for advertising, engagement or optimisation rather than care.
That creates a familiar digital-policy pattern with a new kind of input. If neurodata is gathered in low-friction environments, firms may seek to monetise it directly or use it to enrich behavioural profiles. Even if the raw signals are noisy, combining them with other data sources could make them commercially valuable. In this context, the governance question is not simply whether a headset or sensor works, but what business model sits behind it.
There is also a temporal problem. Data collected for one purpose can acquire new value as decoding methods improve. A neural dataset that seems uninformative today may become far more revealing when analysed with better models tomorrow. This increases the importance of storage limits, technical safeguards and prohibitions on open-ended secondary use.
For policymakers, the lesson is straightforward: neurodata governance should be designed with future inference in mind, not merely present capability. Otherwise regulation will be perpetually surprised by the next software update.
Workplaces, schools and the risk of soft coercion
Few areas illustrate the stakes more clearly than employment and education. Employers have strong incentives to monitor alertness, fatigue and attention in safety-critical sectors. Schools and universities face pressure to measure engagement and optimise learning outcomes. In both cases, neurotechnology can be marketed as supportive, preventive or personalised. Yet these settings are structurally vulnerable to soft coercion.
Workers may fear that refusal signals non-compliance. Students may be unable to opt out without penalty or stigma. Even where participation is nominally voluntary, the surrounding power imbalance can hollow out consent. Moreover, imperfect systems can still shape evaluation. If neural measures become proxies for diligence, focus or honesty, they may entrench new forms of bias against neurodivergent individuals, disabled people or those whose cognitive patterns do not fit standardised norms.
This is one reason many experts argue that certain uses should be prohibited outright rather than merely regulated. Continuous cognitive surveillance for productivity scoring, for instance, sits uneasily with both labour dignity and mental privacy. A similar case can be made against routine neural monitoring of students for discipline or ranking. The point is not that all cognitive measurement is illegitimate. Clinical, accessibility or safety uses may be justified in narrow contexts. But institutions should bear a high burden when seeking access to the mental domain.
Rights language matters, but rights become real only when they are translated into duties on data collection, inference, access, retention and use.
Security, policing and the temptation of exceptionalism
Wherever a technology appears to promise insight into intent or risk, security institutions take interest. Neurotechnology is unlikely to be an exception. That does not mean dramatic scenarios are imminent. It does mean policymakers should prepare for pressure to create exemptions in the name of public order, border control, military readiness or criminal investigation.
History suggests that exceptional powers, once created, tend to expand. The danger is not only abuse, but category error. Technologies that produce probabilistic neural inferences may be granted an aura of objectivity they do not deserve. In adversarial legal or security contexts, that can be corrosive. Standards of evidence, due process and voluntariness are easily distorted when technical systems are poorly understood by courts, officials or the public.
A sound governance framework should therefore begin from scepticism. Compelled neural data extraction should face the strongest possible safeguards. Claims about lie detection, intent recognition or dangerousness should be assessed with rigorous scientific scrutiny, not institutional appetite. Freedom of thought loses much of its meaning if states can treat the mind as a routine evidentiary resource.
How neurodata governance should work
Good governance will need several layers. The first is classification. Law should clearly define neurodata to include both raw neural signals and inferences derived from them. The second is purpose limitation: collection should be tied to specific, legitimate purposes, with strict limits on repurposing. The third is access control and security, including strong encryption, local processing where feasible and narrow retention periods.
The fourth layer is institutional accountability. High-risk neurotechnology systems should be subject to impact assessments, independent audits and meaningful oversight. Individuals should have rights to know when neural data is collected, challenge consequential inferences, withdraw from non-essential processing and seek redress. The fifth is market structure. Policymakers should not assume that competition alone will discipline harmful practices if the underlying business incentive is to extract ever more intimate data.
Some principles are worth stating plainly. Neural data should not be traded like ordinary consumer telemetry. Employers and schools should face stringent limits. Secondary use for advertising or behavioural targeting should be viewed with deep suspicion. Public-interest research and clinical innovation should remain possible, but under robust governance that reflects the sensitivity of the material involved.
International coordination will matter too. Data flows cross borders, and firms can arbitrage weaker jurisdictions. The OECD and UNESCO frameworks provide useful starting points, but domestic implementation remains the decisive test.
The politics of the inner life
The debate over neurotechnology is often presented as a race between innovation and regulation. That framing is too shallow. The deeper issue is political: what kinds of access to the inner life a liberal society is willing to allow, and on what terms. Technologies that can record, infer or modulate aspects of mental life challenge not only privacy rules but older assumptions about where the protected self begins and ends.
That is why cognitive liberty deserves serious attention now, before neural interfaces become mundane infrastructure. Once invasive business models or permissive state practices are normalised, reversing them will be difficult. The aim should not be to freeze a promising field, nor to indulge vague alarmism. It should be to draw boundaries early around coercion, exploitation and unaccountable inference.
The most durable settlement will probably be neither a single grand right nor a patchwork of narrow technical standards, but a layered framework combining human-rights principles, data governance, product regulation, labour protections and sector-specific prohibitions. Neurotechnology is advancing unevenly, but the constitutional question is already clear enough: if societies do not define the terms on which brains can be monitored and influenced, those terms will be set by default, through markets and institutions whose incentives may not align with human freedom.
In that sense, neurotechnology is not only a story about machines meeting minds. It is a test of whether law and democratic norms can keep the inner domain meaningfully private, voluntary and self-directed in an age of increasingly intimate measurement.
